Larry A. Bauer

3.1k total citations
74 papers, 2.4k citations indexed

About

Larry A. Bauer is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Pharmacology. According to data from OpenAlex, Larry A. Bauer has authored 74 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pediatrics, Perinatology and Child Health, 27 papers in Pharmacology and 14 papers in Pharmacology. Recurrent topics in Larry A. Bauer's work include Antibiotics Pharmacokinetics and Efficacy (25 papers), Pharmaceutical studies and practices (18 papers) and Pharmacological Effects and Toxicity Studies (15 papers). Larry A. Bauer is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (25 papers), Pharmaceutical studies and practices (18 papers) and Pharmacological Effects and Toxicity Studies (15 papers). Larry A. Bauer collaborates with scholars based in United States. Larry A. Bauer's co-authors include Robert A. Blouin, John R. Horn, Sandra E. Juul, Ward O. Griffen, Kenneth E. Record, Ronald J. McPherson, RA Blouin, Vidmantas A. Raisys, D J Black and William A. Edwards and has published in prestigious journals such as Neurology, PEDIATRICS and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Larry A. Bauer

74 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Larry A. Bauer United States 25 968 656 375 359 290 74 2.4k
George R. Aronoff United States 32 411 0.4× 822 1.3× 391 1.0× 251 0.7× 305 1.1× 126 3.6k
Ralph E. Cutler United States 32 568 0.6× 459 0.7× 617 1.6× 183 0.5× 266 0.9× 80 3.0k
Gert A. Verpooten Belgium 34 506 0.5× 515 0.8× 361 1.0× 453 1.3× 258 0.9× 107 4.1k
Sarah W. Alander United States 6 1.1k 1.1× 455 0.7× 130 0.3× 161 0.4× 165 0.6× 9 1.9k
Thomas D. Nolin United States 39 736 0.8× 472 0.7× 405 1.1× 292 0.8× 207 0.7× 135 4.3k
B. Whiting United Kingdom 28 460 0.5× 492 0.8× 256 0.7× 157 0.4× 78 0.3× 100 2.3k
John van den Anker United States 31 1.8k 1.8× 608 0.9× 511 1.4× 299 0.8× 199 0.7× 172 3.8k
Jeffrey R. Koup United States 29 755 0.8× 848 1.3× 404 1.1× 138 0.4× 148 0.5× 96 3.2k
Roger K. Verbeeck Belgium 36 807 0.8× 1.2k 1.8× 269 0.7× 336 0.9× 313 1.1× 156 4.7k
Micha Levy Israel 31 404 0.4× 494 0.8× 207 0.6× 77 0.2× 101 0.3× 51 3.5k

Countries citing papers authored by Larry A. Bauer

Since Specialization
Citations

This map shows the geographic impact of Larry A. Bauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry A. Bauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry A. Bauer more than expected).

Fields of papers citing papers by Larry A. Bauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry A. Bauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry A. Bauer. The network helps show where Larry A. Bauer may publish in the future.

Co-authorship network of co-authors of Larry A. Bauer

This figure shows the co-authorship network connecting the top 25 collaborators of Larry A. Bauer. A scholar is included among the top collaborators of Larry A. Bauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry A. Bauer. Larry A. Bauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McPherson, Ronald J., Larry A. Bauer, Todd L. Richards, et al.. (2013). Concurrent Erythropoietin and Hypothermia Treatment Improve Outcomes in a Term Nonhuman Primate Model of Perinatal Asphyxia. Developmental Neuroscience. 35(6). 491–503. 101 indexed citations
2.
Wu, Yvonne W., Larry A. Bauer, Roberta A. Ballard, et al.. (2012). Erythropoietin for Neuroprotection in Neonatal Encephalopathy: Safety and Pharmacokinetics. PEDIATRICS. 130(4). 683–691. 152 indexed citations
3.
McPherson, Ronald J., et al.. (2007). Pharmacokinetics of High-Dose Recombinant Erythropoietin in Plasma and Brain of Neonatal Rats. Pediatric Research. 61(6). 671–675. 113 indexed citations
4.
Agosti, Jan M., et al.. (2001). Aerosolized Protein Delivery in Asthma: Gamma Camera Analysis of Regional Deposition and Perfusion. Journal of Aerosol Medicine. 14(2). 185–195. 41 indexed citations
5.
Bauer, Larry A., et al.. (2000). Effect of Metoprolol and Verapamil Administered Separately and Concurrently after Single Doses on Liver Blood Flow and Drug Disposition. The Journal of Clinical Pharmacology. 40(5). 533–543. 16 indexed citations
6.
Everson, Gregory T., Kenneth C. Lasseter, Karl E. Anderson, et al.. (2000). The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function. British Journal of Clinical Pharmacology. 49(S1). 21–26. 31 indexed citations
7.
Bauer, Larry A., et al.. (1998). Vancomycin dosing in morbidly obese patients. European Journal of Clinical Pharmacology. 54(8). 621–625. 126 indexed citations
8.
Bauer, Larry A., et al.. (1996). Mixed-Effect Modeling for Detection and Evaluation of Drug Interactions: Digoxin-Quinidine and Digoxin-Verapamil Combinations. Therapeutic Drug Monitoring. 18(1). 46–52. 22 indexed citations
9.
Reiss, William, Larry A. Bauer, John R. Horn, et al.. (1994). Acute Effects of Sublingual Nitroglycerin on Hepatic Blood Flow in Healthy Volunteers. The Journal of Clinical Pharmacology. 34(9). 912–918. 4 indexed citations
10.
Bauer, Larry A., Glen T. Schumock, John R. Horn, & Kent E. Opheim. (1992). Verapamil inhibits ethanol elimination and prolongs the perception of intoxication. Clinical Pharmacology & Therapeutics. 52(1). 6–10. 21 indexed citations
11.
O’Sullivan, Teresa A., Larry A. Bauer, John R. Horn, et al.. (1991). Disposition of drugs in cystic fibrosis. II. Hepatic blood flow. Clinical Pharmacology & Therapeutics. 50(4). 450–455. 9 indexed citations
12.
Reiss, William, Larry A. Bauer, John R. Horn, et al.. (1991). The effects of oral nifedipine on hepatic blood flow in humans. Clinical Pharmacology & Therapeutics. 50(4). 379–384. 24 indexed citations
13.
Bauer, Larry A., et al.. (1990). Procainamide – Cimetidine Drug Interaction in Elderly Male Patients. Journal of the American Geriatrics Society. 38(4). 467–469. 15 indexed citations
14.
Bauer, Larry A., et al.. (1990). Single and multiple doses of oral cimetidine do not change liver blood flow in humans. Clinical Pharmacology & Therapeutics. 48(2). 195–200. 12 indexed citations
15.
Horn, John R., Brenda K. Zierler, Larry A. Bauer, William Reiss, & D. Eugene Strandness. (1990). Estimation of Hepatic Blood Flow in Branches of Hepatic Vessels Utilizing a Noninvasive, Duplex Doppler Method. The Journal of Clinical Pharmacology. 30(10). 922–929. 23 indexed citations
16.
Bauer, Larry A., et al.. (1989). Influence of nifedipine therapy on indocyanine green and oral propranolol pharmacokinetics. European Journal of Clinical Pharmacology. 37(3). 257–260. 16 indexed citations
17.
Kradjan, Wayne A., et al.. (1989). Glipizide Pharmacokinetics: Effects of Age, Diabetes, and Multiple Dosing. The Journal of Clinical Pharmacology. 29(12). 1121–1127. 28 indexed citations
18.
Bauer, Larry A., et al.. (1982). The Pharmacokinetics of Thiabendazole and its Metabolites in an Anephric Patient Undergoing Hemodialysis and Hemoperfusion. The Journal of Clinical Pharmacology. 22(5-6). 276–280. 10 indexed citations
19.
Blouin, Robert A., et al.. (1980). Theophylline clearance: Effect of marked obesity. Clinical Pharmacology & Therapeutics. 28(5). 619–623. 19 indexed citations
20.
Blouin, Robert A., et al.. (1980). Theophylline Hemodialysis Clearance. Therapeutic Drug Monitoring. 2(3). 221–224. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George R. Aronoff Breakdown of academic impact, for papers by Ralph E. Cutler Breakdown of academic impact, for papers by Gert A. Verpooten Breakdown of academic impact, for papers by Sarah W. Alander Breakdown of academic impact, for papers by Thomas D. Nolin Breakdown of academic impact, for papers by B. Whiting Breakdown of academic impact, for papers by John van den Anker Breakdown of academic impact, for papers by Jeffrey R. Koup Breakdown of academic impact, for papers by Roger K. Verbeeck Breakdown of academic impact, for papers by Micha Levy
Rankless by CCL
2026